-
SABCS 2024 | Prof. Luke Peppone: Advancing Pharmacotherapy for Chemotherapy-Induced Nausea From Prochlorperazine to Olanzapine
Oncology Frontier：Could you tell us about the original intention of conducting this URCC 16070 phase III randomized controlled trial? Why choose olanzapine and prochlorperazine as agents for nausea caused by…
-
SABCS 2024 | Professor Michael Gnant: Focusing on Breast Cancer, Interpreting New Developments and Future Trends
Oncology Frontier: You and Professor Zhimin Shao jointly presided over the General Session 2 of this conference. As the moderator of this session, could you please give us an overview…
-
Throwback to a Key Study in Breast Cancer Research
A pivotal study published on April 23, 2024, in the Journal of Clinical Oncology explored the efficacy of Datopotamab Deruxtecan (Dato-DXd) in advanced HR+/HER2– and triple-negative breast cancer (TNBC). Led…
-
Current and Future Immunotherapy for Breast Cancer
Published on December 25, 2024, in the Journal of Hematology & Oncology, this review explores the evolving role of immunotherapy in breast cancer treatment, highlighting key advancements in immune checkpoint…
-
ERBB2+ Metastatic Breast Cancer and CNS Disease: Survival Insights
A new study examines survival outcomes and CNS-related mortality among patients with ERBB2+ metastatic breast cancer (MBC) and central nervous system (CNS) disease. Among the 274 patients analyzed, 55.2% of…
-
Advancing Early-Stage HCC Detection: Multicenter Evaluation of Abbreviated MRI vs. Ultrasound
New research evaluates the effectiveness of abbreviated MRI (AMRI) compared to ultrasound in detecting early-stage hepatocellular carcinoma (HCC). Findings suggest that AMRI significantly outperforms ultrasound in sensitivity and specificity, particularly…
-
The World’s Top 2% Scientists List is Out!
Recently, Professor John P.A. Ioannidis and his team from Stanford University, in collaboration with Elsevier, have released the World’s Top 2% Scientists list. This list primarily focuses on the “Career-long Impact” which measures the scientific influence throughout an academic career, as well as the “Single-year Impact” which highlights annual scientific achievements. Based on in-depth analysis…
-
World Breast Cancer Awareness Month | Renowned Physicians’ Protection, Building a Healthy Future Together —— Focusing on Breast Cancer Prevention and Treatment (1)
Professor Qingyuan Zhang（Harbin Medical University Cancer Hospital）： Currently, the incidence of breast cancer worldwide has surpassed that of lung cancer, becoming the number one cancer in humans and seriously threatening…
Connecting Medical Expertise through Media